Literature DB >> 26772778

The Effects of Volume-Controlled and Pressure-Controlled Ventilation on Lung Mechanics, Oxidative Stress, and Recovery in Gynecologic Laparoscopic Surgery.

Chia-Chih Liao1, Yi-Chuan Kau1, Pei-Chi Ting1, Shih-Chang Tsai1, Chin-Jung Wang2.   

Abstract

STUDY
OBJECTIVE: To compare ventilation variables, changes in oxidative stress, and the quality of recovery in 2 different ventilation strategies (volume-controlled ventilation [VCV] and pressure-controlled ventilation [PCV]) during gynecologic laparoscopic surgery.
DESIGN: A prospective randomized controlled trial (Canadian Task Force classification I).
SETTING: One university teaching hospital in Taiwan. PATIENTS: Women scheduled for laparoscopic gynecologic surgery.
INTERVENTIONS: Women were randomly assigned to receive either VCV or PCV during surgery.
MEASUREMENTS AND MAIN RESULTS: Ventilation variables were recorded 1 minute before and 1 hour after pneumoperitoneum. Blood samples were collected for malondialdehyde measurement at 7 points: 1 minute before and 1 hour after pneumoperitoneum; 30, 60, 90, and 120 minutes after deflation; and 24 hours after surgery. Postoperative recovery was assessed by using a 9-item quality of recovery score at 24 hours after surgery. A total of 52 women randomly allocated to the VCV (n = 27) or PCV (n = 25) group completed the study. We found that after 1 hour of insufflation the PCV group had lower peak airway pressure (22.0 ± 3.4 vs 26.6 ± 4.1 cm H2O, p < .0001) and higher compliance (28.4 ± 3.7 vs 24.1 ± 3.3 mL/cm H2O, p < .0001) than the VCV group. In plasma levels of malondialdehyde, there were no significant differences between the 2 groups at 7 time points. The levels significantly increased in both groups after 1 hour of pneumoperitoneum and peaked at 2 hours after deflation. During postoperative recovery, lower scores were obtained at 24 hours after surgery compared with preoperative scores, but there were no significant differences between the 2 groups.
CONCLUSION: PCV is an alternative ventilation mode in gynecologic laparoscopic surgery. However, PCV offered lower peak airway pressure and higher compliance than VCV but no advantages over VCV in oxidative stress or quality of recovery.
Copyright © 2016 AAGL. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Laparoscopy; Oxidative stress; Pneumoperitoneum; Quality of recovery score; Reperfusion injury; Ventilation

Mesh:

Substances:

Year:  2016        PMID: 26772778     DOI: 10.1016/j.jmig.2015.12.015

Source DB:  PubMed          Journal:  J Minim Invasive Gynecol        ISSN: 1553-4650            Impact factor:   4.137


  4 in total

1.  Deferoxamine preconditioning ameliorates mechanical ventilation-induced lung injury in rat model via ROS in alveolar macrophages: a randomized controlled study.

Authors:  Weilin Zhu; Yuansi Huang; Yuqiong Ye; Yafeng Wang
Journal:  BMC Anesthesiol       Date:  2018-08-18       Impact factor: 2.217

2.  Lung ultrasound score-based perioperative assessment of pressure-controlled ventilation-volume guaranteed or volume-controlled ventilation in geriatrics: a prospective randomized controlled trial.

Authors:  Young Sung Kim; Young Ju Won; Dong Kyu Lee; Byung Gun Lim; Heezoo Kim; Il Ok Lee; Jin Hee Yun; Myoung Hoon Kong
Journal:  Clin Interv Aging       Date:  2019-07-18       Impact factor: 4.458

3.  Pressure-controlled ventilation could decrease intraoperative blood loss and improve airway pressure measures during lumbar discectomy in the prone position: A comparison with volume-controlled ventilation mode.

Authors:  Amir Abouzkry El-Sayed; Sherif Kamal Arafa; Ayman Mohamady El-Demerdash
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2019 Oct-Dec

4.  Hydromorphone Protects against CO2 Pneumoperitoneum-Induced Lung Injury via Heme Oxygenase-1-Regulated Mitochondrial Dynamics.

Authors:  Jia Shi; Shi-Han Du; Jian-Bo Yu; Yan-Fang Zhang; Si-Meng He; Shu-An Dong; Yuan Zhang; Li-Li Wu; Cui Li; Hai-Bo Li
Journal:  Oxid Med Cell Longev       Date:  2021-04-09       Impact factor: 6.543

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.